Skip to main content

SB 1580 — Missouri

Modifies provisions relating to ketamine

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

SB 1580 - This act creates a new provision relating to the ordering and administering of ketamine for mental health purposes. The act provides that a licensed physician shall not delegate to any individual the authority to order ketamine hydrochloride for mental health purposes. Further, any licensed physician who delegates the administration of ketamine to a certified registered nurse anesthetist shall be on site and immediately available to supervise and respond during such treatment. Intravenous ketamine hydrochloride treatment for mental health purposes shall not be administered without a documented diagnosis and treatment plan from a physician.

This act is identical to SB 830 (2025) and substantially similar to HB 1043 (2025).
SARAH HASKINS

Official abstract, as published by the legislature.

  • SB 1580 is a bill in the Missouri Senate, 2026 session, introduced January 20, 2026.
  • Sponsored by Jason Bean.
  • Current status: introduced.
  • Most recent action (February 5, 2026): Second Read and Referred S Families, Seniors and Health Committee.
  • Subjects: Drugs and Controlled Substances, Health Care Professionals, Nurses, Physicians.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Jason Bean

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate S First Read
  2. Senate Second Read and Referred S Families, Seniors and Health Committee Latest

Source: Open States. Last checked November 4, 2026. How we keep this accurate ›